128 related articles for article (PubMed ID: 37681448)
1. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
Tsukahara M; So R; Yoshimura Y; Yamashita R; Yada Y; Kodama M; Nakajima S; Kishi Y; Takeda T; Yamada N; Takeuchi H
Acta Psychiatr Scand; 2023 Nov; 148(5):437-446. PubMed ID: 37681448
[TBL] [Abstract][Full Text] [Related]
2. Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study".
Tsukahara M; So R; Yoshimura Y; Nakajima S; Takeuchi H
Acta Psychiatr Scand; 2024 May; 149(5):436-438. PubMed ID: 38359861
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions?
Sangüesa E; Cirujeda C; Concha J; Padilla PP; García CB; Ribate MP
Chem Biol Interact; 2022 Sep; 364():110042. PubMed ID: 35853541
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
Tien Y; Wang XY; Huang SC; Huang HP
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38696112
[No Abstract] [Full Text] [Related]
5. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
[TBL] [Abstract][Full Text] [Related]
6. Association of clozapine and norclozapine levels with patient and therapy characteristics-focus on interaction with valproic acid.
Panić B; Jovanović M; Lukić V; Vučićević K; Miljković B; Milovanović S
Eur J Clin Pharmacol; 2023 Nov; 79(11):1557-1564. PubMed ID: 37733278
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006-2017.
Lin CH; Chan HY; Hsu CC; Chen FC
Sci Rep; 2020 Oct; 10(1):17984. PubMed ID: 33093511
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study.
Hatano M; Kamei H; Takeuchi I; Gomi K; Sakakibara T; Hotta S; Esumi S; Tsubouchi K; Shimizu Y; Yamada S
BMC Psychiatry; 2023 Sep; 23(1):673. PubMed ID: 37715155
[TBL] [Abstract][Full Text] [Related]
9. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study.
Joo SW; Kim H; Jo YT; Ahn S; Choi YJ; Choi W; Park S; Lee J
Eur Neuropsychopharmacol; 2022 Jun; 59():36-44. PubMed ID: 35550204
[TBL] [Abstract][Full Text] [Related]
11. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study.
Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M
Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of clozapine for long-stay patients with treatment-resistant schizophrenia: 4-year observational study.
Mizuno K; Mizuno E; Suekane A; Shiratsuchi T
Neuropsychopharmacol Rep; 2022 Jun; 42(2):183-190. PubMed ID: 35234369
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
[TBL] [Abstract][Full Text] [Related]
14. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Barber S; Olotu U; Corsi M; Cipriani A
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
[TBL] [Abstract][Full Text] [Related]
15. Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia.
Smith RL; Wollmann BM; Kyllesø L; Tran TTA; Tveito M; Molden E
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):43-50. PubMed ID: 34928560
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
17. Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study.
Üçok A; Çıkrıkçılı U; Ergül C; Tabak Ö; Salaj A; Karabulut S; Correll CU
CNS Drugs; 2016 Oct; 30(10):997-1006. PubMed ID: 27356920
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study.
Tsukahara M; So R; Nakajima S; Kitagawa K; Kodama M; Takeuchi H
Int Clin Psychopharmacol; 2023 Mar; 38(2):96-101. PubMed ID: 36165515
[TBL] [Abstract][Full Text] [Related]
19. Can valproic acid be an inducer of clozapine metabolism?
Diaz FJ; Eap CB; Ansermot N; Crettol S; Spina E; de Leon J
Pharmacopsychiatry; 2014 May; 47(3):89-96. PubMed ID: 24764199
[TBL] [Abstract][Full Text] [Related]
20. Clozapine versus typical neuroleptic medication for schizophrenia.
Essali A; Al-Haj Haasan N; Li C; Rathbone J
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD000059. PubMed ID: 19160174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
